The Department of Health – Abu Dhabi (DoH), the regulator for Abu Dhabi’s healthcare sector, and Sanofi, a biopharmaceutical company and vaccines producer, sign a Memorandum of Understanding (MoU) to advance vaccine innovation. The announcement comes from Abu Dhabi on June 23, 2026. Under the MoU, both parties indicate they plan to move toward an additional agreement, with the aim of working together on initiatives related to vaccine development and innovation. The materials provided do not specify the scope of any follow-on agreement, timelines, or particular vaccine candidates or technologies. They also do not give details on funding arrangements, regulatory milestones, or participating institutions beyond the two organizations. As described in the announcement, the partnership is positioned as a collaboration between a healthcare regulator in Abu Dhabi and a global vaccines company, intended to support progress in vaccine-related work. The reported information centers on the signing of the MoU and the intention to finalize further contractual terms.